" class="no-js "lang="en-US"> Laronde - Medtech Alert
Sunday, December 08, 2024
Laronde | Pharmtech Focus

Laronde

About Laronde

Laronde

Laronde is pioneering a platform that offers a completely novel way of modulating human biology. Endless RNA™ (eRNA), is a uniquely engineered RNA that can be programmed to express diverse proteins inside the body. It is persistent, non-immunogenic, allows for repeat dosing, and offers flexibility in formulation and delivery. Laronde was founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering. The company is rapidly scaling to support the parallel development of multiple programs across many disease areas.

Related Story

Laronde Appoints John Mendlein as Chief Executive Officer

August 5 2022

Laronde, the company pioneering Endless RNA™ (eRNA) – a novel, engineered form of RNA that […]

Flagship Pioneering Unveils Laronde to Advance Endless RNA™

May 11 2021

Flagship Pioneering today unveiled Laronde, a platform company developing Endless RNA™ (eRNA), a novel, engineered […]